Comprehensive Clinical Supply Strategies For Compressed Timeline Trials

Drug developers have numerous issues to consider when compressing timelines for clinical studies, from ensuring sufficient study materials will reach the clinic on time, to upholding the integrity of the study. In this Q&A, Gavin Yates, Program Director, CSS and Drug Product Technologies Integrations at Catalent, discusses strategies for mitigating risks and addressing challenges encountered during clinical studies with compressed timelines.